Cidara Therapeutics Inc (CDTX) Rating Lowered to Hold at Zacks Investment Research


According to Zacks, "Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives.



from Biotech News